These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2467748)

  • 21. Induction of interleukin 3 but not interleukin 2 or interferon production in the syngeneic mixed lymphocyte reaction.
    Suzuki R; Suzuki S; Igarashi M; Kumagai K
    J Immunol; 1986 Sep; 137(5):1564-72. PubMed ID: 2427574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggressiveness of SJL/J lymphomas correlates with absence of H-2Ds antigens.
    Rosloniec EF; Kuhn MH; Genyea CA; Reed AH; Jennings JJ; Giraldo AA; Beisel KW; Lerman SP
    J Immunol; 1984 Feb; 132(2):945-52. PubMed ID: 6606680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in vivo depletion of V beta 17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. Evidence for the use of anticlonotypic antibody therapy in the control of malignancy.
    Katz JD; Lebow LT; Bonavida B
    J Immunol; 1989 Aug; 143(4):1387-95. PubMed ID: 2663994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo functional clonal deletion of recipient CD4+ T helper precursor cells that can recognize class II MHC on injected donor lymphoid cells.
    Kiziroglu F; Miller RG
    J Immunol; 1991 Feb; 146(4):1104-12. PubMed ID: 1671401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid viral induction of murine lymphomas in the graft-versus-host reaction.
    Cornelius EA
    J Exp Med; 1972 Dec; 136(6):1533-44. PubMed ID: 4404880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of hybrid Ia molecules on the cell surface of reticulum cell sarcomas that are undetectable on host SJL/J lymphocytes.
    Wilbur SM; Bonavida B
    J Exp Med; 1981 Mar; 153(3):501-13. PubMed ID: 6166700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
    Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
    J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ia-restricted interaction between normal lymphoid cells and SJL lymphoma (RCS) leading to lymphokine production. I. Enhancement and suppression of antibody formation to TI antigens by supernatants and cells from cocultures of RCS and lymphoid cells.
    Hayama T; Nagler C; Umetsu DT; Chapman-Alexander J; Thorbecke GJ
    Cell Immunol; 1983 Jul; 79(1):134-49. PubMed ID: 6222793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of B cells in the stimulation of syngeneic mixed lymphocyte responses.
    Thorbecke GJ; Chapman-Alexander J; Katz IR; Bienenstock A; Asofsky R
    Behring Inst Mitt; 1983 May; (72):107-16. PubMed ID: 6242330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The SJL/J T cell response to both spontaneous and transplantable syngeneic reticulum cell sarcoma is mediated predominantly by the V beta 17a+ T cell clonotype.
    Katz JD; Ohnishi K; Lebow LT; Bonavida B
    J Exp Med; 1988 Nov; 168(5):1553-62. PubMed ID: 2460577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
    Kern DE; Klarnet JP; Cheever MA; Greenberg PD
    Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
    Ohnishi K; Bonavida B
    J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
    Mizuochi T; Ono S; Malek TR; Singer A
    J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MHC-linked Ir gene control of T cell responses: GAT-specific proliferating T cells and helper T cells are elicited in nonresponder mice immunized with soluble GAT.
    Gougeon ML; Theze J
    J Immunol; 1983 Apr; 130(4):1521-6. PubMed ID: 6187811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of anti-donor allohelper T cells after neonatal induction of allotolerance in mice.
    Abramowicz D; Vandervorst P; Bruyns C; Doutrelepont JM; Vandenabeele P; Goldman M
    Eur J Immunol; 1990 Aug; 20(8):1647-53. PubMed ID: 2145162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection from spontaneous lymphoma development in SJL/J(v+) mice neonatally injected with dualtropic SJL-151 virus.
    De Rossi A; D'Andrea E; Biasi G; Collavo D; Chieco-Bianchi L
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2775-9. PubMed ID: 6601806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inappropriate alloantigen-like specificities detected on reticulum cell sarcomas of SJL/J mice: characterization and biologic role.
    Bonavida B; Roman JM; Hutchinson IV
    Transplant Proc; 1980 Mar; 12(1):59-64. PubMed ID: 6154360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiotype-specific helper cells (BH) express immunoglobulin markers and employ T cell function-associated molecules.
    Sherr DH; Ju ST
    J Immunol; 1986 Dec; 137(11):3406-13. PubMed ID: 2946760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
    Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC
    Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.